INNO-LiPA® HPV Genotyping Extra II
FujirebioLine probe assay, based on the reverse hybridization principle, designed for the identification of 32 different genotypes of the human papillomavirus (HPV).
Fujirebio Products & Reviews
25
Fujirebio is global R&D-driven company constantly developing new in vitro diagnostics testing technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care. Our global teams located in Japan, Asia, Europe, and the US focus on delivering products with the highest quality standards to our customers and partners. We value CDMO partnerships with many of the world’s leading diagnostic companies, sharing knowledge, capabilities, and critical materials to supply, develop, or manufacture diagnostic solutions on a wide variety of platforms.
Selected Filters:
PreCursor-M+
FujirebioQualitative detection of promotor hypermethylation of 2 cervical cancer associated genes (FAM19A4 and hsa-miR124-2). Identify HPV positive women with high short-term progression to (pre)cancer.
HPV-Risk assay
FujirebioQualitative detection of 14 high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68) as well as putative HPV high risk type 67, with separate identification of HPV16 and 18 in one test. Fully clinically validated HPV screening method to identify women at risk for cervical (pre)cancer using either cervical scrape or self-collected vaginal sample.
AmpFire® HPV Screening 16/18/HR
FujirebioQualitative detection of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube. Fast. Simple. Accurate.
AmpFire® HPV High Risk Genotyping
FujirebioQualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate.
PreCursor-M AnoGYN (RUO)
FujirebioPreCursor-M AnoGYN is a methylation-specific molecular assay to detect promoter hypermethylation of the human genes ASCL1 and ZNF582 in bisulfite-converted DNA prepared from human samples, for instance formalin-fixed paraffin embedded anal biopsies or anal swab specimens.
Lumipulse® G NfL Blood (RUO)
FujirebioImmunoassay to be used with the automated LUMIPULSE G System for the quantitative measurement of neurofilament light (NfL) in human plasma and serum.
Lumipulse® G pTau 217 Plasma (RUO)
FujirebioImmunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human K2EDTA plasma.
Lumipulse® G pTau 181 Plasma (RUO)
FujirebioImmunoassay to be used with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 181 (pTau 181) in human plasma.
Lumipulse® G β-Amyloid 1-40 Plasma (RUO)
FujirebioImmunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human plasma.